Several lymphocyte surface antigens are encoded by genes in the Mls region on mouse chromosome 1 [Mls, Festenstein et al. 1977; Ly-9, Ledbetter et al. 1979, Hogarth et al. 1980, Mathieson et al. 1980; Ly-17 (Ly-m20), Shen and Boyse 1980, Kimura et al. 1981; Ly-22, Tada et al. 1983]. In this report we describe a new Ly antigen (Ly-33) which is controlled by a gene linked to the Ly-17 locus on chromosome 1. A hybridoma line, N19.310, was obtained by the fusion of NS-1 myeloma cells with spleen cells from a GR/A mouse which was hyperimmunized with ASL-1, an A strain-derived T-cell tumor. N19.310 secretes IgM(K) immunoglobulin as determined by immunodiffusion (Ouchterlony and Nilsson 1978). Tissue distribution of the Ly-33 alloantigen was determined by using the direct cytotoxicity assay previously described by Kimura and coworkers (1980). With rabbit serum as a complement source, the antibody lysed 90%, 100%, 100%, and 70% of celts in thymus, lymph node, spleen, and bone marrow, respectively. The expression of the Ly-33 alloantigen on nonlymphoid tissues was tested by cytotoxicity absorption assay using the homogenates obtained from brain, liver, and kidney. They all absorbed the cytotoxic activity of Ly-33-specific antibody (data not shown). The strain distribution of the Ly-33 alloantigen was assessed by testing lymph node cells of a panel of inbred strains including CXS recombinant inbred strains, derived from the cross between BALB/c and STS/A (Michalides et al. 1985). The result is summarized in Table 1. The strain distribution of Ly-33 in CXS RI strains suggests a linkage between Ly-33 and Ly-17, as only three recombinants are found among 14 strains (Michalides et al. 1985; J. Hilgers, personal communication). To confirm the linkage and determine the position of Ly-33 on chromosome 1, a three-point cross experiment was performed by using Ly-22, Ly-17, and Ly-33 loci in (BALB.B x GR/A)F 1 x GR/A backcross mice. As shown in Table 2, among 135 backcross mice, 33, 27, and 8 recombinants between Ly-33 and